Showing results (591-600 of 1,243) with videos related to

Sort By:
Pageof 125
The American Journal of Cardiology|February 6, 2017
Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal FunctionPatrick H Pun, Shubin Sheng, Gillian Sanders, et al.
Circulation. Heart Failure|May 17, 2014
Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studySelma F Mohammed, Barry A Borlaug, Steven McNulty, et al.
American Heart Journal|June 20, 2012
Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failureLesley H Curtis, Xiaojuan Mi, Laura G Qualls, et al.
Circulation|September 22, 2022
Assessing the Impact of the American Heart Association's Research Portfolio: A Scientific Statement From the American Heart AssociationMark A Creager, Adrian F Hernandez, Jeffrey R Bender, et al.
American Heart Journal|December 3, 2014
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare populationRichard K Cheng, Margueritte Cox, Megan L Neely, et al.
American Heart Journal|August 25, 2015
Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF)Jacob P Kelly, Robert J Mentz, Vic Hasselblad, et al.
Journal of the American Heart Association|March 26, 2013
A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic strokeEric E Smith, Nandavar Shobha, David Dai, et al.
Circulation. Heart Failure|January 14, 2016
Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in WomenEmily P Zeitler, Anne S Hellkamp, Phillip J Schulte, et al.
American Heart Journal|June 20, 2017
Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomesTiffany C Randolph, Anne S Hellkamp, Emily P Zeitler, et al.
ESC Heart Failure|November 21, 2019
Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failureAbhinav Sharma, Jingjing Wu, Justin A Ezekowitz, et al.
Pageof 125